• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. VENA CAVA FILTER Back to Search Results
Catalog Number UNKNOWN FILTER
Device Problems Detachment of Device or Device Component (2907); Unintended Movement (3026); Patient Device Interaction Problem (4001)
Patient Problem Abdominal Pain (1685)
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: the device history record (dhr) could not be performed as the lot number is unknown.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately ten and half months post filter deployment, ct revealed a linear radiopaque density within the right renal hilum which appeared to be within renal artery and most likely represented an embolized fragment of the ivc filter.Also, the ivc filter was positioned with majority of the filter above the level of renal veins.Subsequent radiopaque density seen on prior radiograph also revealed, a detached fragment of the ivc filter was not appreciated on this exam and may have changed its location.Nine days later, the patient presented with abdominal pain and back pain.Subsequent ct revealed, presence of filter fragments in the parenchyma and not in iliac or renal vasculature.Approximately one year later, ct revealed filter partially displaced but there was no evidence of perforation or inflammation.Eventually a year later, ct revealed the presence of fractured filter struts as seen in previous examinations.The ivc filter was identified with its apex approximately 7.5mm superior to the point of entry of the left renal vein.The position remained unchanged from previous examinations.Also, there appeared to be 2 rows of struts.A more superior row of struts had only one of them present at this time and these appeared to be within the confines of the ivc and adjoining renal vein.A more inferior row of struts appeared to extend beyond the confines of the ivc wall and most likely represented some caval perforation from these struts.Conceivably one of these struts had fractured and has extended into the region of the right renal hilum and is unchanged from previous examinations.There is also noted a metallic wire within the right lower lobe pulmonary artery which is felt to be secondary to embolization of a strut into the right lower lobe pulmonary artery following a fracture of a strut from the ivc filter.Therefore, the investigation is confirmed for filter limb detachment, perforation of the ivc and unintended movement.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism.At some time post filter deployment, it was alleged that the filter detached and struts perforated into the organs.The device has not been removed and there were no reported attempts made to retrieve the filter.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA CAVA FILTER
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key9449170
MDR Text Key170214062
Report Number2020394-2019-05436
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 12/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN FILTER
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/22/2019
Initial Date FDA Received12/11/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AMLODIPINE, ASTELIN, HYDROCODONE-ACETAMINOPHEN; LISONOPRIL, MELOXICAM, NEURONTIN, OXYCODONE; PRAVASTATIN, PRILOSEC; VITAMIN D, LOVENOX, COUMADIN
Patient Outcome(s) Other;
Patient Weight77
-
-